Fresenius Medical Care Appoints Shervin J. Korangy as New CEO
Fresenius Medical Care announced that Shervin J. Korangy will become the new Chief Executive Officer (CEO) and Chair of the Management Board, effective October 12, 2026. He succeeds Helen Giza, who has led the company for the past four years. Korangy, who has served on the company's Supervisory Board since 2023, brings significant global executive experience in healthcare and life sciences, most recently as CEO of BVI Medical. The company stated that under Giza's leadership, FME optimized its portfolio and implemented the FME25+ transformation program, creating a strong foundation for future growth. Ann Custin has been identified as a potential successor for Korangy's position on the Supervisory Board.
Key Highlights
- Shervin J. Korangy appointed CEO and Chair of the Management Board, effective October 12, 2026.
- Helen Giza steps down as CEO and Chair after four years in the role.
- Korangy previously served on Fresenius Medical Care's Supervisory Board since 2023.
- Korangy brings extensive leadership experience from healthcare and life sciences, including his recent role as CEO of BVI Medical.
- Ann Custin identified as a successor for the Supervisory Board, pending court proceedings.
Price Impact
More from FMS
Fresenius Medical Care Files Q2 2026 Interim Report; Details Reclassification
Fresenius Medical Care Appoints Cassie McLean to Management Board
Fresenius Medical Care Q2 Operating Income +23%; Reaffirms FY26 Outlook